 Adrenergic alpha-2 Receptor Agonists
"Adrenergic alpha-2 Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS.
| Descriptor ID |
D058647
|
| MeSH Number(s) |
D27.505.519.625.050.100.100.200 D27.505.696.577.050.100.100.200
|
| Concept/Terms |
Adrenergic alpha-2 Receptor Agonists- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha 2 Receptor Agonists
- Adrenergic alpha2-Agonists
- Adrenergic alpha2 Agonists
- alpha2-Agonists, Adrenergic
- Adrenergic alpha-2 Agonists
- Adrenergic alpha 2 Agonists
- Agonists, Adrenergic alpha-2
- alpha-2 Agonists, Adrenergic
- Adrenergic alpha-2 Receptor Agonist
- Adrenergic alpha 2 Receptor Agonist
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic alpha-2 Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic alpha-2 Receptor Agonists".
This graph shows the total number of publications written about "Adrenergic alpha-2 Receptor Agonists" by people in UAMS Profiles by year, and whether "Adrenergic alpha-2 Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 0 | 1 | 1 | | 2022 | 0 | 1 | 1 | | 2017 | 1 | 0 | 1 | | 2016 | 1 | 1 | 2 | | 2015 | 0 | 1 | 1 | | 2012 | 1 | 0 | 1 | | 2004 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenergic alpha-2 Receptor Agonists" by people in Profiles over the past ten years.
-
Obeng S, Crowley ML, Mottinelli M, Le?n F, Zuarth Gonzalez JD, Chen Y, Gamez-Jimenez LR, Restrepo LF, Ho NP, Patel A, Martins Rocha J, Alvarez MA, Thadisetti AM, Park CR, Pallares VLC, Milner MJ, Canal CE, Hampson AJ, McCurdy CR, McMahon LR, Wilkerson JL, Hiranita T. The Mitragyna speciosa (kratom) alkaloid mitragynine: Analysis of adrenergic a2 receptor activity in vitro and in vivo. Eur J Pharmacol. 2024 Oct 05; 980:176863.
-
Obeng S, Leon F, Patel A, Zuarth Gonzalez JD, Chaves Da Silva L, Restrepo LF, Gamez-Jimenez LR, Ho NP, Guerrero Calvache MP, Pallares VLC, Helmes JA, Shiomitsu SK, Soto PL, McCurdy CR, McMahon LR, Wilkerson JL, Hiranita T. Interactive Effects of ?-Opioid and Adrenergic-a2 Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine. J Pharmacol Exp Ther. 2022 12; 383(3):182-198.
-
Yeo QM, Wiley TL, Smith MN, Hammond DA. Oral Agents for the Management of Agitation and Agitated Delirium in Critically Ill Patients. Crit Care Nurs Q. 2017 Oct/Dec; 40(4):344-362.
-
Brotherton AL, Hamilton EP, Kloss HG, Hammond DA. Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature. Pharmacotherapy. 2016 Apr; 36(4):433-42.
-
Black BT, Soden SE, Kearns GL, Jones BL. Clinical and Pharmacologic Considerations for Guanfacine Use in Very Young Children. J Child Adolesc Psychopharmacol. 2016 08; 26(6):498-504.
-
Stein MA, Sikirica V, Weiss MD, Robertson B, Lyne A, Newcorn JH. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial. CNS Drugs. 2015 Nov; 29(11):953-62.
-
Tanghetti EA, Jackson JM, Belasco KT, Friedrichs A, Hougier F, Johnson SM, Kerdel FA, Palceski D, Hong HC, Hinek A, Cadena MJ. Optimizing the use of topical brimonidine in rosacea management: panel recommendations. J Drugs Dermatol. 2015 Jan; 14(1):33-40.
|
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|